Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging System After Preoperative Systemic Therapy of Breast Cancer in Multi-center in China

NCT03437837 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT03437837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03437837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging System After Preoperative Systemic Therapy of Breast Cancer in Multi-center in China
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Completed
Start date
May 1, 2017
Completion date
September 29, 2018
Enrollment
1,077 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, estrogen receptor, her2, histological grade, neoadjuvant therapy, neoplasm staging, predictive value of tests, prognosis